绿新生物科技有限公司（01084.HK）于2026年2月2日披露截至2026年1月31日止的月度证券变动情况。报告显示，公司法定股本维持在50,000,000,000股，面值每股0.01港元，总额为500,000,000港元，较上月无变化。
本月底已发行股份总数保持在874,120,000股，期间无新增发行、购回或注销，也无库藏股变动。公司确认，目前公众持股量符合监管要求。
据公告信息所示，报告期内无股份期权、权证或可换股票据等其他股本变动，股本整体维持稳定。公司强调已遵守香港联交所《上市规则》及相关法律规定。此月报由公司秘书苏智文签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.